Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of KESTRA MEDICAL TECHNOLOGIES, LTD. from 30 Apr 2023 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
KESTRA MEDICAL TECHNOLOGIES, LTD. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD history and change rate from 30 Apr 2023 to 31 Oct 2025.
  • KESTRA MEDICAL TECHNOLOGIES, LTD. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending 31 Oct 2025 was $164,081,000.
Source SEC data
View on sec.gov
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)

KESTRA MEDICAL TECHNOLOGIES, LTD. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $164,081,000 +$400,626,000 31 Oct 2025 10-Q 11 Dec 2025 2025 Q2
Q2 2025 $184,159,000 +$400,630,000 31 Jul 2025 10-Q 11 Dec 2025 2025 Q2
Q1 2025 $205,406,000 +$414,783,000 30 Apr 2025 10-Q 11 Dec 2025 2025 Q2
Q3 2024 $236,545,000 31 Oct 2024 10-Q 11 Dec 2025 2025 Q2
Q2 2024 $216,471,000 31 Jul 2024 10-Q 11 Dec 2025 2025 Q2
Q1 2024 $209,377,000 -$91,799,000 -78% 30 Apr 2024 10-Q 11 Dec 2025 2025 Q2
Q1 2023 $117,578,000 30 Apr 2023 10-K 17 Jul 2025 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.